Loading clinical trials...
Loading clinical trials...
To explore the 5-year overall survival (OS) of right versus left thoracic surgical approaches for patients with locally advanced Siewert II gastroesophageal junction adenocarcinoma treated by neoadjuv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
NCT04423354 · Esophagogastric Junction Adenocarcinoma, Siewert Type II Adenocarcinoma of Esophagogastric Junction
NCT04151524 · Oesophagus Cancer, Barrett Esophagus, and more
NCT03416101 · Siewert Type II Adenocarcinoma of Esophagogastric Junction
NCT01504256 · Gastric Adenocarcinoma With Peritoneal Carcinomatosis, Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis, and more
Cancer Hospital Chinese Academy of Medical Sciences
Beijing
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions